NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

What did these pharma marketers think they were going to hear by inviting bioethicist Carl Elliott?

Posted By

Categories

Tags

The DTC (direct to consumer) National Conference (“The Forum for DTC Thought Leaders”) invited tough-talking, straight-shooting bioethicist Carl Elliott to speak this year.

Then, at least according to this account, some didn’t like “the feeling” that he imparted. Scroll down to “Day One – Afternoon.” If you didn’t want to hear that “everything is broken – our government, our healthcare system, and the clinical trials side of the industry,” then maybe Elliott was not the guy to invite.

Health care journalists who haven’t had the opportunity to meet Elliott can do so this weekend at the Association of Health Care Journalists conference in Philadelphia, where he’ll be on a panel, “Clinical trials: Intersection of ethical, practical and financial.” Hint: If you don’t want to hear what’s broken, don’t come.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Gary Schwitzer's HealthNewsReview Blog

April 21, 2011 at 11:41 am

Pfizer’s $100,000 Fellowships in Bioethics – a bioethicist’s view

On his bioethics seminar’s “Fear and Loathing in Bioethics” blog, Dr. Carl Elliott has commented on – first – the announcement of applications for $100,000 Pfizer Fellowships in Bioethics. This is a screenshot from the Fear & Loathing blog: And…